ArticleUpdates in surgery2026
Application of left lateral hepatolithiasis classification in minimally invasive hepatectomy.
Article in Updates in surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
Left lateral hepatolithiasis is the most common subtype of intrahepatic bile duct stones. Although minimally invasive left lateral sectionectomy (MLS) is widely applied, postoperative stone recurrence remains frequent, particularly in the B4 bile duct. This study aimed to evaluate the clinical value of a classification based on B4 bile duct orifice involvement and to explore optimal minimally invasive surgical strategies. A retrospective analysis was performed on 238 patients with left lateral hepatolithiasis who underwent minimally invasive surgery between January 2015 and October 2024. Patients were classified into B4 type (stones compressing or obstructing the B4 bile duct orifice) and Non-B4 type. Perioperative outcomes, postoperative complications, stone recurrence, and long-term outcomes were compared. Subgroup analyses were conducted in B4-type patients undergoing MLS or conversion to middle hepatic vein-guided anatomical left hemihepatectomy combined with transhepatic lithotomy (MATL). Logistic regression analyses were used to identify independent risk and protective factors. Compared with the Non-B4 group, B4-type patients had longer operative time, greater blood loss, and significantly higher rates of bile leakage and stone recurrence. Multivariate analysis identified B4 bile duct orifice involvement as an independent risk factor for postoperative bile leakage (OR 16.58, p < 0.001) and stone recurrence (OR 30.87, p < 0.001). Conversion to MATL was an independent protective factor against bile leakage (OR 0.04, p = 0.003) and stone recurrence (OR 0.10, p = 0.003). In B4-type patients, MATL was associated with lower complication and recurrence rates without increasing perioperative risk. Left lateral hepatolithiasis involving the B4 bile duct orifice represents a more complex subtype with higher surgical risk and recurrence potential. Individualized surgical planning based on detailed preoperative imaging and intraoperative findings is essential. MATL may be a valuable option in selected B4-type patients.
Indexed as
Identifiers
42223899What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.